Variant report

Variant	nsv604
Chromosome Location	chr12:10144039-10160440
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:32)
CpG islands
(count:183)
Chromatin interactive
region (count:1)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:32 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr12:10153919-10154049	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr12:10158320-10158470	HCPEpiC	choroid plexus:	n/a	chr12:10158357-10158378 chr12:10158362-10158380
3	CTCF	chr12:10150933-10151026	MCF-7	breast:	n/a	n/a
4	CTCF	chr12:10150957-10151045	Kidney_OC	kidney:	n/a	n/a
5	CTCF	chr12:10158333-10158370	GM12878	blood:	n/a	n/a
6	CTCF	chr12:10150920-10151045	GM19239	blood:	n/a	n/a
7	CTCF	chr12:10150942-10151028	GM12878	blood:	n/a	n/a
8	CTCF	chr12:10156980-10157130	HEK293	kidney:	n/a	n/a
9	CTCF	chr12:10150955-10151019	NHEK	skin:	n/a	n/a
10	CTCF	chr12:10150917-10151039	GM12892	blood:	n/a	n/a
11	CTCF	chr12:10158280-10158430	HMEC	breast:	n/a	chr12:10158357-10158378 chr12:10158362-10158380
12	CTCF	chr12:10150938-10151046	GM19238	blood:	n/a	n/a
13	CTCF	chr12:10150912-10151036	MCF-7	breast:	n/a	n/a
14	CTCF	chr12:10150934-10151038	A549	lung:	n/a	n/a
15	CTCF	chr12:10150927-10151011	MCF-7	breast:	n/a	n/a
16	CTCF	chr12:10150866-10150997	H1-hESC	embryonic stem cell:	n/a	n/a
17	CTCF	chr12:10150964-10150997	Gliobla	brain:	n/a	n/a
18	CTCF	chr12:10150935-10151031	MCF-7	breast:	n/a	n/a
19	CTCF	chr12:10150944-10151010	Hela-S3	cervix:	n/a	n/a
20	CTCF	chr12:10150945-10151001	GM19240	blood:	n/a	n/a
21	CTCF	chr12:10150931-10150933	A549	lung:	n/a	n/a
22	CTCF	chr12:10150959-10150985	MCF-7	breast:	n/a	n/a
23	E2F4	chr12:10145847-10145860	MCF10A-Er-Src	breast:	n/a	n/a
24	EBF1	chr12:10152767-10152773	GM12878	blood:	n/a	n/a
25	GATA3	chr12:10146312-10146451	SH-SY5Y	brain:	n/a	n/a
26	MAZ	chr12:10146252-10146343	HepG2	liver:	n/a	n/a
27	POLR2A	chr12:10156692-10156739	A549	lung:	n/a	n/a
28	POLR2A	chr12:10150877-10151021	A549	lung:	n/a	n/a
29	SPI1	chr12:10155490-10155822	HL-60	blood:	n/a	n/a
30	SPI1	chr12:10144945-10145314	HL-60	blood:	n/a	chr12:10145101-10145114 chr12:10145102-10145115 chr12:10145104-10145113
31	SPI1	chr12:10144477-10144937	HL-60	blood:	n/a	chr12:10144680-10144693
32	SPI1	chr12:10144938-10145387	HL-60	blood:	n/a	chr12:10145101-10145114 chr12:10145102-10145115 chr12:10145104-10145113

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:10153316-10153366	GM12891	blood:	n/a
2	chr12:10151707-10151757	LNCaP	prostate:	n/a
3	chr12:10153316-10153366	CMK	blood:	n/a
4	chr12:10153316-10153366	GM19239	blood:	n/a
5	chr12:10151707-10151757	GM06990	blood:	n/a
6	chr12:10153316-10153366	Jurkat	blood:	n/a
7	chr12:10150905-10150955	HepG2	liver:	n/a
8	chr12:10150905-10150955	HL-60	blood:	n/a
9	chr12:10153316-10153366	U87	brain:	n/a
10	chr12:10151707-10151757	GM19239	blood:	n/a
11	chr12:10150905-10150955	AG04449	skin:	fetal
12	chr12:10153316-10153366	ovcar-3	ovarian:	n/a
13	chr12:10150905-10150955	H1-hESC	embryonic stem cell:	embryo
14	chr12:10150905-10150955	HAEpiC	amniotic membrane:	n/a
15	chr12:10150905-10150955	SAEC	small airway:	n/a
16	chr12:10150905-10150955	AG09319	gingival:	n/a
17	chr12:10151707-10151757	K562	blood:	n/a
18	chr12:10153316-10153366	HCM	heart:	n/a
19	chr12:10151707-10151757	HIPEpiC	eye:	n/a
20	chr12:10151707-10151757	Jurkat	blood:	n/a
21	chr12:10153316-10153366	HCPEpiC	choroid plexus:	n/a
22	chr12:10150905-10150955	PFSK-1	brain:	n/a
23	chr12:10151707-10151757	ECC-1	luminal epithelium:	n/a
24	chr12:10151707-10151757	HRE	kidney:	n/a
25	chr12:10153316-10153366	AG09319	gingival:	n/a
26	chr12:10150905-10150955	MCF10A-Er-Src	breast:	n/a
27	chr12:10151707-10151757	HEEpiC	esophagus:	n/a
28	chr12:10153316-10153366	AG09309	skin:	n/a
29	chr12:10150905-10150955	ECC-1	luminal epithelium:	n/a
30	chr12:10153316-10153366	AG04450	lung:	fetal
31	chr12:10151707-10151757	HMEC	breast:	n/a
32	chr12:10153316-10153366	A549	lung:	n/a
33	chr12:10151707-10151757	A549	lung:	n/a
34	chr12:10151707-10151757	HCM	heart:	n/a
35	chr12:10151707-10151757	T-47D	breast:	n/a
36	chr12:10150905-10150955	Caco-2	colon:	n/a
37	chr12:10150905-10150955	HEEpiC	esophagus:	n/a
38	chr12:10150905-10150955	AG04450	lung:	fetal
39	chr12:10151707-10151757	PANC-1	pancreas:	n/a
40	chr12:10150905-10150955	SK-N-MC	brain:	n/a
41	chr12:10153316-10153366	HEK293	kidney:	embryo
42	chr12:10153316-10153366	SK-N-SH	brain:	n/a
43	chr12:10150905-10150955	NHDF-neo	bronchial:	n/a
44	chr12:10150905-10150955	BJ	skin:	n/a
45	chr12:10153316-10153366	SK-N-MC	brain:	n/a
46	chr12:10151707-10151757	NHBE	bronchial:	n/a
47	chr12:10150905-10150955	HCF	heart:	n/a
48	chr12:10151707-10151757	HRPEpiC	eye:	n/a
49	chr12:10150905-10150955	HEK293	kidney:	embryo
50	chr12:10151707-10151757	GM12891	blood:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr12:9910779..9913756-chr12:10153448..10156029,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CLEC12B-1	chr12:10147617-10148293	NONHSAT026857

No data

Variant related genes	Relation type
CLEC1B	TF binding region
CLEC12B	TF binding region
CLEC1B	CpG island
CLEC12B	CpG island
ENSG00000110848	chromatin interactions

Extended variants
information (count: 730 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:730 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs193140940	chr12:10144044-10144045	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs538162690	chr12:10144051-10144052	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs185663111	chr12:10144062-10144063	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs141535393	chr12:10144159-10144160	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs539894264	chr12:10144196-10144197	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs531425	chr12:10144246-10144247	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
7	rs115518238	chr12:10144251-10144252	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs542089870	chr12:10144288-10144289	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs529232913	chr12:10144315-10144316	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs568794485	chr12:10144320-10144321	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs531085707	chr12:10144326-10144327	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs563194539	chr12:10144341-10144342	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs74636970	chr12:10144351-10144352	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs150455067	chr12:10144369-10144370	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs533368955	chr12:10144443-10144444	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs547113697	chr12:10144477-10144478	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs566894998	chr12:10144495-10144496	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs118094739	chr12:10144510-10144511	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs189170866	chr12:10144526-10144527	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs138552829	chr12:10144527-10144528	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs58266182	chr12:10144547-10144548	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs569047967	chr12:10144585-10144586	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs376707954	chr12:10144660-10144661	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs181541590	chr12:10144678-10144679	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs35301185	chr12:10144680-10144681	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs11053537	chr12:10144698-10144699	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs17807046	chr12:10144863-10144864	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs60634266	chr12:10144987-10144988	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs12299203	chr12:10145022-10145023	Enhancers Bivalent Enhancer Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs542731858	chr12:10145057-10145058	Enhancers Bivalent Enhancer Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs34850701	chr12:10145105-10145106	Enhancers Bivalent Enhancer Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs114107563	chr12:10145123-10145124	Enhancers Bivalent Enhancer Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs539853256	chr12:10145126-10145127	Enhancers Bivalent Enhancer Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs74527042	chr12:10145142-10145143	Enhancers Bivalent Enhancer Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs532071001	chr12:10145144-10145145	Enhancers Bivalent Enhancer Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs544875214	chr12:10145190-10145191	Enhancers Bivalent Enhancer Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs185754954	chr12:10145226-10145227	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs536166912	chr12:10145262-10145263	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs613871	chr12:10145341-10145342	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
40	rs540665746	chr12:10145343-10145344	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs547363788	chr12:10145361-10145362	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs529334471	chr12:10145371-10145372	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs549464503	chr12:10145382-10145383	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs146198541	chr12:10145389-10145390	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs562496583	chr12:10145401-10145402	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs531448596	chr12:10145450-10145451	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs565594907	chr12:10145529-10145530	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs71450015	chr12:10145587-10145588	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs368407925	chr12:10145725-10145726	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs15635	chr12:10145731-10145732	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Hepatocellular carcinoma	16750200	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21611746	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Squamous cell cancer	19607727	CNVD
Prostate cancer	16573809	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Glioblastoma multiforme	22286061	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Acute myeloid leukemia	17268525	CNVD
Acute monocytic leukemia	16498392	CNVD
Prostate cancer	16461572	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17133270	CNVD

Chromatin state (count:63 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:10129200-10144400	Weak transcription	Primary hematopoietic stem cells	blood
2	chr12:10135800-10144600	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
3	chr12:10140800-10144400	Weak transcription	Primary neutrophils fromperipheralblood	blood
4	chr12:10143400-10144200	Enhancers	Monocytes-CD14+_RO01746	blood
5	chr12:10144000-10145200	Enhancers	Primary monocytes fromperipheralblood	blood
6	chr12:10144200-10144400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
7	chr12:10144200-10144600	Enhancers	Brain Anterior Caudate	brain
8	chr12:10144200-10144800	Bivalent Enhancer	Primary B cells from cord blood	blood
9	chr12:10144200-10145000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
10	chr12:10144400-10144600	Enhancers	Brain Hippocampus Middle	brain
11	chr12:10144400-10144600	Enhancers	Brain Inferior Temporal Lobe	brain
12	chr12:10144400-10144800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr12:10144400-10145000	Enhancers	Primary hematopoietic stem cells short term culture	blood
14	chr12:10144400-10145600	Enhancers	Primary hematopoietic stem cells	blood
15	chr12:10144400-10145800	Enhancers	Primary neutrophils fromperipheralblood	blood
16	chr12:10144400-10145800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
17	chr12:10144600-10144800	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
18	chr12:10144600-10144800	Flanking Active TSS	Brain Hippocampus Middle	brain
19	chr12:10144600-10145000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
20	chr12:10144600-10145000	Enhancers	Brain Angular Gyrus	brain
21	chr12:10144600-10145000	Active TSS	Brain Inferior Temporal Lobe	brain
22	chr12:10144800-10145200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr12:10144800-10145200	Active TSS	Brain Anterior Caudate	brain
24	chr12:10144800-10145200	Active TSS	Brain Hippocampus Middle	brain
25	chr12:10144800-10146000	Enhancers	Primary B cells from cord blood	blood
26	chr12:10145000-10145200	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
27	chr12:10145000-10145200	Active TSS	Monocytes-CD14+_RO01746	blood
28	chr12:10145000-10146000	Weak transcription	Brain Angular Gyrus	brain
29	chr12:10145200-10146200	Enhancers	Brain Hippocampus Middle	brain
30	chr12:10145200-10155400	Weak transcription	Monocytes-CD14+_RO01746	blood
31	chr12:10145200-10155800	Weak transcription	Primary monocytes fromperipheralblood	blood
32	chr12:10145800-10153400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
33	chr12:10146000-10146400	Enhancers	Brain Angular Gyrus	brain
34	chr12:10146000-10146400	Enhancers	Brain Substantia Nigra	brain
35	chr12:10149400-10149800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
36	chr12:10149400-10150000	Enhancers	Placenta Amnion	Placenta Amnion
37	chr12:10149800-10153400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr12:10150000-10153200	Weak transcription	Placenta Amnion	Placenta Amnion
39	chr12:10150800-10151800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
40	chr12:10151800-10152000	Enhancers	Primary hematopoietic stem cells short term culture	blood
41	chr12:10152000-10153800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
42	chr12:10153200-10154400	Enhancers	Placenta Amnion	Placenta Amnion
43	chr12:10153400-10154000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr12:10153400-10154000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
45	chr12:10153800-10154200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
46	chr12:10153800-10154400	Enhancers	Primary hematopoietic stem cells short term culture	blood
47	chr12:10153800-10154400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr12:10154000-10154200	Bivalent Enhancer	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
49	chr12:10154000-10154400	Enhancers	Primary hematopoietic stem cells	blood
50	chr12:10154000-10154400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links